TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/07 14:01 | 12/17/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Stephen | WA | O | CTO | M.d | 6 | 0.5600 | 4 | 10 | 143 | 17 | D | -14 | 4 | -38 | -27 | -18 | -11 | -12 | -1 | 4 | 5 | -16 | -5 | -27 | -46 |
3/16/07 19:08 | 3/16/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Stephen | WA | O | VP,Chief | M.ad | 3 | 0.4386 | 4 | 7 | New | 7 | D | 0 | -20 | 14 | 29 | -5 | -7 | -10 | -3 | -1 | 5 | 14 | 26 | 17 | -25 |
3/16/07 13:39 | 3/16/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Stephen | WA | O | VP,Chief | M.d | 3 | 0.4386 | 4 | 7 | New | 7 | D | 0 | -20 | 14 | 29 | -5 | -7 | -10 | -3 | -2 | 3 | 12 | 24 | 15 | -27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |